Aurobindo gets USFDA nod to market heart disease drug
Aurobindo Pharma has received US health regulator's approval to market Eptifibatide Injection, used in the treatment of acute coronary syndrome, in the American market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cardiology | Eptifibatide | Health | Heart | Heart Disease | Integrilin | Pharmaceuticals